Similar companies
| Company | Linkedin Employees | |
|---|---|---|
 |
AmgenAMGN |
41,827 |
 |
Gilead SciencesGILD |
14,851 |
 |
Inovio PharmaceuticalsINO |
201 |
 |
BridgeBio PharmaBBIO |
1,064 |
 |
Crispr TherapeuticsCRSP |
339 |
How Many Employees Does Inhibikase Therapeutics Have?
Inhibikase Therapeutics (IKT) has 38 employees according to LinkedIn, up 18.8% over the past three months. Headcount growth at this pace signals active expansion — hiring to scale operations, R&D, or go-to-market. The LinkedIn count includes everyone who lists Inhibikase Therapeutics as their current employer, so it reflects workforce changes sooner than the 9 reported in Inhibikase Therapeutics’s most recent official filing.
With 38 employees, Inhibikase Therapeutics has a smaller workforce than industry peers like Amgen (41,827) and Gilead Sciences (14,851).
Is Inhibikase Therapeutics Growing or Shrinking?
Employee count is one of the most reliable leading indicators in alternative data: companies tend to hire before they grow and cut before they report weakness. AltIndex feeds Inhibikase Therapeutics’s headcount into the IKT AI Score alongside job postings, employee business outlook, and 20+ other signals.
For more on Inhibikase Therapeutics’s workforce, see its job postings, employee business outlook, and employee ratings. For a demand-side read, see Inhibikase Therapeutics web traffic.
Month over Month
| Sep 2026 | 33 | |
| Aug 2026 | 32 | |
| Jul 2026 | 32 | |
| Jun 2026 | 31 | |
| May 2026 | 30 |
Inhibikase Therapeutics Employees & Headcount: Frequently Asked Questions
Inhibikase Therapeutics has 38 employees according to LinkedIn, compared with 9 reported in its most recent official filings. The LinkedIn figure counts everyone who lists Inhibikase Therapeutics as their current employer, so it reflects workforce changes sooner than annual filings.
Inhibikase Therapeutics’s headcount has grown 18.8% over three months, indicating active hiring. View the headcount trend chart above for the full history.
Headcount is a leading indicator: companies typically hire before revenue accelerates and reduce staff before earnings disappoint. No single data point predicts a stock on its own, which is why AltIndex combines Inhibikase Therapeutics’s headcount with job postings, employee business outlook, and 20+ other signals in its AI Score.
Inhibikase Therapeutics underperforms its industry peers when it comes to Linkedin Employees, ranking dead last.
Sign up and get more insights on Inhibikase Therapeutics.
See Inhibikase Therapeutics’s complete linkedin employees history
Sign up to unlock 1-year and all-time charts for IKT, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
